Tissue drug concentration determines whether fluorescence or absorption measurements are more sensitive in diffuse optical tomography of exogenous contrast agents

Applied Optics

Volumn 48, Issue 10, 2009, Pages

  Davis, Scott C ^a   Pogue, Brian W ^a   Dehghani, Hamid ^a,b   Paulsen, Keith D ^a  

^a DARTMOUTH COLLEGE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPTICAL TOMOGRAPHY; TISSUE;

ABSORPTION MEASUREMENTS; ABSORPTION PROPERTY; DIFFUSE OPTICAL TOMOGRAPHY; ELEVATED CONCENTRATIONS; FLUORESCENCE MEASUREMENTS; MEASUREMENT SENSITIVITY; RELATIVE PERTURBATION; SENSITIVE MEASUREMENT;

FLUORESCENCE;

DIAGNOSTIC AGENT; FLUORESCENT DYE;

ABSORPTION; ARTICLE; BIOLOGICAL MODEL; BREAST; BREAST TUMOR; COMPARATIVE STUDY; COMPUTER SIMULATION; DIFFERENTIAL THRESHOLD; DRUG EFFECT; FEMALE; FLUORESCENCE; HUMAN; METABOLISM; METHODOLOGY; OPTICAL TOMOGRAPHY; OSMOLARITY; SENSITIVITY AND SPECIFICITY;

ABSORPTION; BREAST; BREAST NEOPLASMS; COMPUTER SIMULATION; DIFFERENTIAL THRESHOLD; FEMALE; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL;

EID: 65249160618     PISSN: 1559128X     EISSN: 15394522     Source Type: Journal    
DOI: 10.1364/AO.48.00D262     Document Type: Article

References (37)

1. V. Ntziachristos, C. H. Tung, C. Bremer, and R. Weissleder, "Fluorescence molecular tomography resolves protease activity in vivo," Nat. Med. 8, 757-760 (2002).
2. E. Graves, J. Ripoll, R. Weissleder, and V. Ntziachristos, "A submillimeter resolution fluorescence molecular imaging system for small animal imaging," Med. Phys. 30, 901-911 (2003).
3. V. Ntziachristos, E. A. Schellenberger, J. Ripoll, D. Yessayan, E. Graves, A. Bogdanov, Jr., L. Josephson, and R. Weissleder, "Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate," Proc. Natl. Acad. Sci. U.S.A. 101, 12294-12299 (2004).
4. E. E. Graves, R. Weissleder, and V. Ntziachristos, "Fluorescence molecular imaging of small animal tumor models," Curr. Mol. Med. 4, 419-430 (2004).
5. R. B. Schulz, J. Ripoll, and V. Ntziachristos, "Experimental fluorescence tomography of tissues with noncontact measurements," IEEE Trans. Med. Imaging 23, 492-500 (2004).
6. G. Zacharakis, J. Ripoll, R. Weissleder, and V. Ntziachristos, "Fluorescent protein tomography scanner for small animal imaging," IEEE Trans. Med. Imaging 24, 878-885 (2005).
7. S. V. Patwardhan, S. R. Bloch, S. Achilefu, and J. P. Culver, "Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice," Opt. Express 13, 2564-2577(2005).
8. E. E. Graves, D. Yessayan, G. Turner, R. Weissleder, and V. Ntziachristos, "Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography," J. Biomed. Opt. 10, 044019 (2005).
9. A. Godavarty, M. J. Eppstein, C. Zhang, and E. M. Sevick- Muraca, "Detection of single and multiple targets in tissue phantoms with fluorescence-enhanced optical imaging: feasibility study," Radiology (Oak Brook, 111.) 235, 148-154 (2005).
10. A. Godavarty, A. B. Thompson, R. Roy, M. Gurfinkel, M. J. Eppstein, C. Zhang, and E. M. Sevick-Muraca, "Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies," J. Biomed. Opt. 9, 488-496 (2004).
11. A. Godavarty, C. Zhang, M. J. Eppstein, and E. M. Sevick- Muraca, "Fluorescence-enhanced optical imaging of large phantoms using single and simultaneous dual point illumination geometries," Med. Phys. 31, 183-190 (2004).
12. A. Corlu, R. Choe, T Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, "Three- dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans," Opt. Express 15, 6696-6716 (2007).
13. M. Gurfinkel, A. B. Thompson, W. Ralston, T. L. Troy, A. L. Moore, T. A. Moore, J. D. Gust, D. Tatman, J. S. Reynolds, B. Muggenburg, K. Nikula, R. Pandey, R. H. Mayer, D. J. Hawrysz, and E. M. Sevick-Muraca, "Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study," Photochem. Photobiol. 72, 94-102 (2000).
14. D. J. Cuccia, F. Bevilacqua, A. J. Durkin, S. Merritt, B. J. Tromberg, G. Gulsen, H. Yu, J. Wang, and O. Nalcioglu, "In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration," Appl. Opt. 42, 2940-2950 (2003).
15. G. Gulsen, H. Yu, J. Wang, O. Nalcioglu, S. Merritt, F. Bevilacqua, A. J. Durkin, D. J. Cuccia, R. Lanning, and B. J. Tromberg, "Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors," Tech- nol. Cancer Res. Treat. 1, 497-505 (2002).
16. E. M. C. Hillman and A. Moore, "All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast," Nat. Photonics 1, 526-530 2007).
17. B. Alacam, B. Yazici, X. Intes, S. Nioka, and B. Chance, "Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods," Phys. Med. Biol. 53, 837-859 (2008).
18. X. Intes, J. Ripoll, Y. Chen, S. Nioka, A. G. Yodh, and B. Chance, "In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green," Med. Phys. 30, 1039-1047 (2003).
19. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, "Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement," Proc. Natl. Acad. Sci. USA 97, 2767-2772 (2000).
20. C. Bremer, V. Ntziachristos, and R. Weissleder, "Optical-based molecular imaging: contrast agents and potential medical applications," Eur. Radiol. 13, 231-243 (2003).
21. T. F. Massoud and S. S. Gambhir, "Molecular imaging in living subjects: seeing fundamental biological processes in a new light," Genes Dev. 17, 545-580 (2003).
22. V. Ntziachristos, "Fluorescence molecular imaging," Annu. Rev. Biomed. Imaging 8, 1-33 (2006).
23. R. Weissleder and U. Mahmood, "Molecular imaging," Radiology (Oak Brook, 111.) 219, 316-336 (2001).
24. E. M. Sevick-Muraca, G. Lopez, J. S. Reynolds, T. L. Troy, and C.L. Hutchinson, "Fluorescence and absorption contrast mechanisms for biomedical optical imaging using frequency- domain techniques," Photochem. Photobiol. 66, 55-64 (1997).
25. X. Li, B. Chance, and A. G. Yodh, "Fluorescent heterogeneities in turbid media: limits for detection, characterization, and comparison with absorption," Appl. Opt. 37,6833-6844 (1998).
26. M. J. Eppstein, D. J. Hawrysz, A. Godavarty, and E. M. Sevick-Muraca, "Three-dimensional, Bayesian image reconstruction from sparse and noisy data sets: near-infrared fluorescence tomography," Proc. Natl. Acad. Sci. USA 99, 9619-9624 (2002).
27. D. J. Hawrysz and E. M. Sevick-Muraca, "Development toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents," Neoplasia 2, 388-417 (2000).
28. H. B. Jiang, "Frequency-domain fluorescent diffusion tomography: a finite-element-based algorithm and simulations," Appl. Opt. 37, 5337-5343 (1998).
29. A. B. Milstein, O. Seungseok, K. J. Webb, C. A. Bouman, Q. Zhang, D. A. Boas, and R. P. Millane, "Fluorescence optical diffusion tomography," Appl. Opt. 42, 3081-3094 (2003).
30. D. Y. Paithankar, A. U. Chen, B. W. Pogue, M. S. Patterson, and E. M. Sevick-Muraca, "Imaging of fluorescent yield and lifetime from multiply scattered light reemitted from random media," Appl. Opt. 36, 2260-2272 (1997).
31. S. C. Davis, H. Dehghani, J. Wang, S. Jiang, B. W. Pogue, and K D. Paulsen, "Image-guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization," Opt. Express 15, 4066-4082 (2007).
32. H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K D. Paulsen, "Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction," Com-mun. Numer. Methods Eng. doi: 10.1002/cnm, in press.
33. A. Corfu, T. Durduran, R. Choe, M. Schweiger, E. M. Hillman, S. R. Arridge, and A. G. Yodh, "Uniqueness and wavelength optimization in continuous-wave multispectral diffuse optical tomography," Opt. Lett. 28, 2339-2341 (2003).
34. A. Li,Q. Zhang, J. Culver,E. Miller, andD. Boas, "Reconstructing chromophore concentration images directly by continuous- wave diffuse optical tomography," Opt. Lett. 29,256-258 (2004).
35. S. Srinivasan, B. W. Pogue, B. Brooksby, S. Jiang, H. Dehghani, C. Kogel, W A. Wells, S. P. Poplack, and K. D. Paulsen, "Near-infrared characterization of breast tumors in vivo using spectrally-constrained reconstruction," Technol. Cancer Res. Treat. 4, 513-526 (2005).
36. S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K D. Paulsen, "In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction," Acad. Radiol. 13, 195-202 (2006).
37. S. C. Davis, B. W. Pogue, S. Srinivasan, H. Dehghani, and K. D. Paulsen, "Development of spectrally-constrained diffuse optical tomography for imaging exogenous contrast agents," in Biomedical Optics, OSA Technical Digest Series (CD) (Optical Society of America, 2006), paper SH36.